Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines

Clinical Biochemistry

Volumn 36, Issue 4, 2003, Pages 247-253

  Salami, Siamak ^a   Karami Tehrani, Fatemeh ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Apoptosis; Bax and Bcl 2 proteins; Caspase 3; MCF 7; MDA MB468; Tamoxifen

Indexed keywords

CASPASE 3; ESTROGEN RECEPTOR; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BCL 2; TAMOXIFEN; TRYPTOPHAN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL LINE; CELL PROLIFERATION; CHEMICAL ANALYSIS; CHI SQUARE TEST; COLORIMETRY; CYTOTOXICITY; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; STAINING; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 0037841605     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(03)00007-9     Document Type: Article

References (36)

1. Song Z., Steller H. Death by design mechanism and control of apoptosis . Trend Cell Biol. 9:1999;m49-m52.
2. Reed J.C. Dysregulation of apoptosis in cancer. J Clin Oncol. 17:1999;2941-2953.
3. Tompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
4. Soini Y., Paakko P., Lehto V.-P. Histopathological evaluation of apoptosis in cancer. Am J Patholo. 153:1998;1041-1053.
5. Thornberry N.A., Lazebnik Y. Caspases enemies within . Science (Washington DC). 281:1998;1312-1316.
6. Izban K.F., Wrone-Smith T., Hsi E.D., Shcnitzer B., Ouevedo M.E., Alkan S. Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin’s disease lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin’s disease . Am J Pathol. 154:1999;1439-1447.
7. Kroemer G. The proto-oncogene bcl-2 and its role in regulating apoptosis. Nat Med. 3:1997;614-620.
8. Mc Pherson K., Steel C.M., Dixon J.M. ABC of the breast diseases, breast cancer epidemiology, risk factors, and genetics. Br Med J. 321:2000;624-628.
9. Parton M., Dowsett M., Smith I. Studies of apoptosis in breast cancer. Br Med J. 322:2001;1528-1532.
10. Wyld D.K., Chester J.D., Perren T.J. Endocrine aspect of the clinical management of the breast cancer- current issues. Endocr Relat Cancer. 58:1998;97-110.
11. Jordan V.C. Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res Treat. 31:1994;41-52.
12. Mandlekar S., Kong A.N.T. Mechanisms of tamoxifen–induced apoptosis. Apoptosis. 6:2001;469-477.
13. Wilson A.J., Tehrani F., Baum M. Adjuvant tamoxifen therapy for early breast cancer an experimental study with reference to estrogen and progesterone receptor . Br J Surg. 69:1982;121-125.
14. Friedman Z.Y. Recent advances in understanding the molecular mechanisms of tamoxifen action. Cancer Inves. 16:1998;391-396.
15. Karami-Tehrani F., Salami S., Mokarram P. Competition of tamoxifen with thyroxine for TBG binding ligand binding assay and computational data . Clin Biochem. 34:2001;603-606.
16. Carthew P., Nolan B.M., Edwards R.E., Smith L.L. The role of cell death and cell proliferation in the promotion of rat liver tumours by tamoxifen. Cancer Lett. 106:1996;163-169.
17. Ercoli A., Scambia G., Fattorossi A., Raspaglio G., Battaglia A., Cicchillitti L., Malorni W., Rainaldi G., Benedetti Panici P., Mancuso S. Comparative study on the induction of cytostasis and apoptosis by ICI 182,780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell line. Int J Cancer. 76:1998;47-54.
18. Robinson E.K., Grau A.M., Evans D.B., Smid C.M., Chiao P.J., Abbruzzese J.L., Grimm E.A. Cell cycle regulation of human pancreatic cancer by tamoxifen. Ann Surg Oncol. 5:1998;342-349.
19. Zhang W., Couldwell W.T., Song H., Takano T., Lin J.H., Nedergaard M. Tamoxifen-induced enhancement of calcium signaling in glioma, and MCF-7 breast cancer cells. Cancer Res. 60:2000;5395-5400.
20. Darzynkiewicz Z., Traganos F. Measurement of apoptosis. Adv Biochem Eng/Biotechnol. 62:1998;33-73.
21. Engeland M.V., Nieland L.J.W., Ramaekers F.C.S., Schutte B., Reutelingsperger C.P.M. Annexin V-affinity assay a review on an apoptosis detection system based on phosphatidylserine exposure . Cytometry. 31:1998;1-9.
22. Budtz P.E. Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with estradiol and/or tamoxifen. Cell Prolif. 32:1999;289-302.
23. Otto A.M., Paddenberg R., Schubert S., et al. Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin. J Cancer Res Clin Oncol. 122:1996;603-612.
24. Hashimoto M., Inoue S., Muramatsu M., et al. Estrogens stimulate tamoxifen-induced neuronal cell apoptosis in vitro a possible nongenomic action . Biochem Biophys Res Commu. 240:1997;464-470.
25. Ferlini C., Scambia G., Marone M., et al. Tamoxifen induces oxidative stress and apoptosis in estrogen receptor-negative human cancer cell lines. Br J Cancer. 79:1999;257-263.
26. Gurtu V., Kain R.S., Zhang G. Fluormetric, and colorimetric detection of caspase activity associated with apoptosis. Anal Biochem. 251:1997;98-102.
27. Janicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 required for DNA fragmentation, and morphological changes associated with apoptosis. J Biol Chem. 273:1998;9357-9360.
28. Squier M.K., Miller A.C., Malkinson A.M., Cohen J.J. Calpain activation in apoptosis. J Cell Physiol. 159:1994;229-237.
29. Mandlekar S., Yu R., Tan T.H., Kong A.N. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res. 60:2000;5995-6000.
30. Zhang G.J., Kimijima I., Onda M. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels. Clin Cancer Res. 5:1999;2971-2977.
31. Kang Y., Cortina R., Perry R.R. Role of c-myc in tamoxifen-induced apoptosis in the estrogen-independent breast cancer cells. J Natl Cancer Inst. 88:1996;279-284.
32. 2+ and inorganic phosphate. Toxicol Appl Pharmacol. 152:1998;1-7.
33. 2+ influx in the mechanism of tamoxifen-induced apoptosis in HepG2 human hepatoblastoma cells. Cancer Lett. 147:1999;115-123.
34. Mac Callum J., Cummings J., Dixon J.M., Miller W.R. Concentration of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours. Br J Cancer. 82:2000;1629-1635.
35. Frankfurt O.S., Sugarbaker E.V., Robb J.A., Villa L. Synergistic induction of apoptosis in breast cancercells by tamoxifen and calmoduline inhibitors. Cancer Lett. 97:1995;149-154.
36. Couldwell W.T., Hinton D.R., Surnock A.A., et al. Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen. Clin Cancer Res. 2:1996;619-622.